(Q34188979)

31 July 2017

Low dose ketamine increases prepulse inhibition in healthy men. (English)

1 reference

31 July 2017

Kathryn M Abel

1

0 references

author name string

Matthew P G Allin

series ordinal

2

1 reference

PubMed ID

12681371

31 July 2017

David R Hemsley

series ordinal

3

1 reference

PubMed ID

12681371

31 July 2017

Mark A Geyer

series ordinal

4

1 reference

31 July 2017

1 May 2003

1 reference

31 July 2017

1 reference

31 July 2017

44

1 reference

31 July 2017

6

1 reference

31 July 2017

729-737

1 reference

Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Repeated testing of prepulse inhibition and habituation of the startle reflex: a study in healthy human controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Observations on the psychotomimetic effects of Sernyl.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Sensorimotor gating and habituation evoked by electro-cutaneous stimulation in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Sensorimotor gating and schizophrenia. Human and animal model studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Prestimulus effects on human startle reflex in normals and schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Gating and habituation of the startle reflex in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Behavioral effects of phencyclidine and ketamine alone and in combination with other drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Schizophrenia: a subcortical neurotransmitter imbalance syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Inhibition of mammalian brain acetylcholinesterase by ketamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

The effect of 1-arylcylohexylamine (sernyl) on twelve normal volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

On the clinical and cognitive meaning of impaired sensorimotor gating in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

The effects of smoking on acoustic prepulse inhibition in healthy men and women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Clinical and sensorimotor gating effects of ketamine in normals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

The PCP psychosis: prolonged intoxication or drug-precipitated functional illness?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Startle response models of sensorimotor gating and habituation deficits in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Presidential Address, 1974. The more or less startling effects of weak prestimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Startle gating deficits occur across prepulse intensities in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

The psychotropic effect of ketamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

The effects of sub-anaesthetic doses of ketamine on memory, cognitive performance and subjective experience in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

A mechanism to inhibit input activation and its dysfunction in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

The acoustic startle response in rats--circuits mediating evocation, inhibition and potentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Subanesthetic doses of ketamine stimulate psychosis in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Model psychoses and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Dopaminergic stimulation disrupts sensorimotor gating in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Comparison of ketamine and pethidine in experimental and postoperative pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Bimodal electrodermal activity in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Clinical features of latent inhibition in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Test-retest reliability of prepulse inhibition of the acoustic startle response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Properties of the optical isomers and metabolites of ketamine on the high affinity transport and catabolism of monoamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900073-X

10.1016/S0028-3908(03)00073-X

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12681371